Mon, April 4, 2011
[ Mon, Apr 04th 2011 ] - Market Wire
New International Surgical Products Business Prov .. cing Medline's Evidence-Based Solutions Worldwide
[ Mon, Apr 04th 2011 ] - Market Wire
Noted Oregon Cardiologists Conduct First Study on .. ts Using VentriPoint 3D Heart Analysis Technology
[ Mon, Apr 04th 2011 ] - Market Wire
Rosetta Genomics Reports 2010 Fourth Quarter and Full Year Financial Results
[ Mon, Apr 04th 2011 ] - Market Wire
Implant Sciences Announces Fiscal 2011 Q2 Revenue .. 3,147,000, Up 422% vs. Same Period in Fiscal 2010
[ Mon, Apr 04th 2011 ] - Market Wire
Peregrine Presents Phase Ib HCV/HIV Data on Single-Agent Bavituximab at EASL
[ Mon, Apr 04th 2011 ] - Market Wire
Medisafe 1 Technologies Garners Interest From Mul .. al Medical Supplier Becton, Dickinson and Company
[ Mon, Apr 04th 2011 ] - Market Wire
Salix Reviews the International Liver Congress 20 .. e European Association for the Study of the Liver
[ Mon, Apr 04th 2011 ] - Market Wire
Abiomed Announces Schedule of Events at American College of Cardiology 2011 Scientific Conference
[ Mon, Apr 04th 2011 ] - Market Wire
Abiomed Announces Final PROTECT II Study Results .. ulation at American College of Cardiology 2011 Sc
[ Mon, Apr 04th 2011 ] - Market Wire
ImmunoGen, Inc. Announces First Data for Its IMGN529 Product Candidate for Non-Hodgkina?s Lymphoma
[ Mon, Apr 04th 2011 ] - Market Wire
AngioDynamics Launches the Next Generation DuraMax® Stepped-Tip Chronic Dialysis Catheter
[ Mon, Apr 04th 2011 ] - Market Wire
ImmunoGen, Inc. Announces First Data for its Nove .. erapeutic for Ovarian Cancer and Other Carcinomas
Sun, April 3, 2011
[ Sun, Apr 03rd 2011 ] - Market Wire
Antrim Energy and Partners to Drill East Fyne Well, UK North Sea
[ Sun, Apr 03rd 2011 ] - Market Wire
Sanofi-aventis Successfully Completes Exchange Offer for Genzyme Corporation
[ Sun, Apr 03rd 2011 ] - Market Wire
Economic Analysis Demonstrating Cost Effectiveness of Edwards SAPIEN Valve Presented at ACC
[ Sun, Apr 03rd 2011 ] - Market Wire
Edwards Lifesciences Achieves Primary Endpoint in .. theter Valve Study of High-Risk Surgical Patients
Sat, April 2, 2011
[ Sat, Apr 02nd 2011 ] - Market Wire
Orthofix Appoints Vicente Trelles as Senior Vice .. sident, World Wide Operations and Shared Services
[ Sat, Apr 02nd 2011 ] - Market Wire
Investigational Compound PEG-Interferon Lambda Ac .. with Fewer Flu-Like and Musculoskeletal Symptoms
[ Sat, Apr 02nd 2011 ] - Market Wire
Medtronic Announces FDA Approval of InterStim® Therapy for Bowel Control
[ Sat, Apr 02nd 2011 ] - Market Wire
MEDNAX 2011 First Quarter Conference Call/Webcast Scheduled for Tuesday May 3, 2011
Fri, April 1, 2011
[ Fri, Apr 01st 2011 ] - Market Wire
Shoal Point Energy Ltd. Provides 3K39 Well Update
[ Fri, Apr 01st 2011 ] - Market Wire
MedMira Announces Second Quarter Results
[ Fri, Apr 01st 2011 ] - Market Wire
LABOPHARM RECEIVES NOTICE FROM NASDAQ REGARDING MINIMUM MARKET VALUE OF LISTED SECURITIES
[ Fri, Apr 01st 2011 ] - Market Wire
PromiusTM Pharma and Valeant Form Collaboration to Market Cloderm® Cream in the United States
[ Fri, Apr 01st 2011 ] - Market Wire
Data on IPX066 APEX-PD Phase III Study for the Tr .. s Disease to be Presented at the American Academy
[ Fri, Apr 01st 2011 ] - Market Wire
Aethlon Medical Discloses Part II of Emerging Opportunities in Biodefense Interview
[ Fri, Apr 01st 2011 ] - Market Wire
St Eugene Commences 2011 Exploration Program at Tartan Lake Mine Project
[ Fri, Apr 01st 2011 ] - Market Wire
Equity Research on Aetna Inc. and Unitedhealth Gr .. nc. - Health Care Providers Positioned for Growth
[ Fri, Apr 01st 2011 ] - Market Wire
Equity Research on Medtronic Inc. and St. Jude Me .. , Implantable Defibrillators Pumping Up Medical A
[ Fri, Apr 01st 2011 ] - Market Wire
AVI BioPharma Prices $30.0 Million Public Offering of Common Stock
[ Fri, Apr 01st 2011 ] - Market Wire
Liberty Metals & Mining Exercises Participation R .. Million IFC Financing for Further Proceeds of Up
[ Fri, Apr 01st 2011 ] - Market Wire
MEDNAX Announces the Acquisition of Practices in San Antonio, TX and Miami, FL
Thu, March 31, 2011
[ Thu, Mar 31st 2011 ] - Market Wire
Biogen Idec et Knopp Biosciences annoncent le rec .. ent dans une ©tude mondiale de phase III portant
[ Thu, Mar 31st 2011 ] - Market Wire
Anmeldung der ersten Patienten fr weltweite Phase .. I-Studie ber Dexpramipexol zur Behandlung von ALS
[ Thu, Mar 31st 2011 ] - Market Wire
ImmunoCellular Therapeuticsa? ICT-107 Named One of the 100 Great Investigational Drugs for 2011
[ Thu, Mar 31st 2011 ] - Market Wire
MEDIA ADVISORY - Oncolytics Biotech® Inc. to .. sent at 10th Annual Needham Healthcare Conference
[ Thu, Mar 31st 2011 ] - Market Wire
Apthera and RXi Pharmaceuticals Announce Definitive Merger Agreement
[ Thu, Mar 31st 2011 ] - Market Wire
AVEO Pharmaceuticals, Inc. to Present at the Leerink Swann Cancer Roundtable Conference
[ Thu, Mar 31st 2011 ] - Market Wire
SuperGen PIM Kinase Presentations at AACR
[ Thu, Mar 31st 2011 ] - Market Wire
SuperGen to Webcast 5th Annual Investor & Analyst Day on April 12, 2011
[ Thu, Mar 31st 2011 ] - Market Wire
A.P. Pharma Announces Transfer to OTCQB
[ Thu, Mar 31st 2011 ] - Market Wire
Inhibitex Reports Positive Safety and Antiviral D .. hase 1b Study of HCV Nucleotide Inhibitor INX-189
[ Thu, Mar 31st 2011 ] - Market Wire
Inhibitex Announces Data Presentation at the 46th .. ean Association for the Study of the Liver (EASL)
[ Thu, Mar 31st 2011 ] - Market Wire
The New England Journal of Medicine Publishes Stu .. ational Medicine VICTRELISa" (boceprevir) in Comb
Wed, March 30, 2011
[ Wed, Mar 30th 2011 ] - Market Wire
CIGNA betritt Privatkundensegment mit neuer Krankenversicherung CIGNA Global Health Options
[ Wed, Mar 30th 2011 ] - Market Wire
CIGNA entra nel mercato sanitario globale per le persone lanciando CIGNA Global Health Options
[ Wed, Mar 30th 2011 ] - Market Wire
Antrim Energy Inc. Announces the Filing of Its National Instrument 51-101 Reports
[ Wed, Mar 30th 2011 ] - Market Wire
Baby, It's Cold Outside, But Pharmaceutical Industry Is Hot, an Industrial Info News Alert
[ Wed, Mar 30th 2011 ] - Market Wire
Bernstein Liebhard LLP Announces Investigation of Offer for Cephalon, Inc.
[ Wed, Mar 30th 2011 ] - Market Wire
Yale and Gilead Sciences Announce Cancer Research Collaboration
[ Wed, Mar 30th 2011 ] - Market Wire
Curis Announces Presentations at 102nd American A .. sociation for Cancer Research Annual Meeting 2011
[ Wed, Mar 30th 2011 ] - Market Wire
Medivation and Astellas Announce Initiation of Ph .. ng MDV3100 With Bicalutamide in Advanced Prostate
[ Wed, Mar 30th 2011 ] - Market Wire
BioSante Pharmaceuticals Completes Enrollment in Both Pivotal LibiGel® Phase III Efficacy Trials
[ Wed, Mar 30th 2011 ] - Market Wire
Derma Sciences Reports Fourth Quarter Results; Sa .. oducts up 59% over Prior Year; Total Net Sales Ne
[ Wed, Mar 30th 2011 ] - Market Wire
Dr. Reddya?s Announces Completion of the Acquisit .. cillin Facility and Products from GlaxoSmithKline
[ Wed, Mar 30th 2011 ] - Market Wire
Columbia Laboratories' Provides Update on PREGNANT Study Publication
Tue, March 29, 2011
[ Tue, Mar 29th 2011 ] - Market Wire
Somaxon Pharmaceuticals Announces Issuance of Pat .. ting to Pharmacokinetics (Food Effect) of Silenor
[ Tue, Mar 29th 2011 ] - Market Wire
Merc Completes Final Tranche of Private Placement
[ Tue, Mar 29th 2011 ] - Market Wire
ACADIA Pharmaceuticals to Present at the Tenth An .. al Needham Healthcare Conference on April 5, 2011
[ Tue, Mar 29th 2011 ] - Market Wire
Biomagneticsa? Updates on Commercialization of the IOBS Unit
[ Tue, Mar 29th 2011 ] - Market Wire
NuPathe to Present at the 10th Annual Needham Healthcare Conference
[ Tue, Mar 29th 2011 ] - Market Wire
(NYSE Amex: DXR) Daxor Corporation Announces Year End 2010 Earnings
[ Tue, Mar 29th 2011 ] - Market Wire
Curis to Present at the 10th Annual Needham Healthcare Conference
[ Tue, Mar 29th 2011 ] - Market Wire
Derma Sciences Advanced Wound Care Products Featu .. tions at the Diabetic Foot Global Conference 2011
[ Tue, Mar 29th 2011 ] - Market Wire
Phase 3 Study of VX-770 in Children Ages 6 to 11 .. c Fibrosis Showed Profound Improvements in Lung F
[ Tue, Mar 29th 2011 ] - Market Wire
Advisory Contract between Medwell Capital and Spectral Diagnostics Increases
[ Tue, Mar 29th 2011 ] - Market Wire
Medical Facilities Corporation Proposes Conversion to Traditional Common Share Structure
[ Tue, Mar 29th 2011 ] - Market Wire
ZIOPHARM to Present at Upcoming Investor Conferences
Mon, March 28, 2011
[ Mon, Mar 28th 2011 ] - Market Wire
Clinical and Economic Data From The PARTNER Trial to Be Presented at ACC 2011
[ Mon, Mar 28th 2011 ] - Market Wire
Medtronic to Unveil Pivotal U.S. Data on Resolute® Drug-Eluting Stent at ACC.11
[ Mon, Mar 28th 2011 ] - Market Wire
Cambridge Hearta?s MTWA Test Featured as Case of .. Week in Diagnostic and Interventional Cardiology
[ Mon, Mar 28th 2011 ] - Market Wire
EnteroMedics Receives CE Mark Certification for t .. g Australian Regulatory Application to Move Forwa
[ Mon, Mar 28th 2011 ] - Market Wire
PacificHealth Laboratories Launches ACCEL RECOVER(R)
[ Mon, Mar 28th 2011 ] - Market Wire
CytRx Announces the Presentation of Bafetinib Stu .. Academy for Cancer Research (AACR) Annual Meeting
[ Mon, Mar 28th 2011 ] - Market Wire
AVI BioPharma Names Peter S. Linsley, Ph.D., Chief Scientific Officer
[ Mon, Mar 28th 2011 ] - Market Wire
Implant Sciences Announces $380,000 in New Contra .. Quantum Sniffer Explosives Trace Detection Device
[ Mon, Mar 28th 2011 ] - Market Wire
Treating Skeletal Muscle Injuries With Pluristem's PLacental eXpanded (PLX) Cells
[ Mon, Mar 28th 2011 ] - Market Wire
Dr. Reddya?s Launches Levocetirizine Tablets in US
[ Mon, Mar 28th 2011 ] - Market Wire
Preclinical Data on AVEO Pharmaceuticalsa? Tivoza .. ipeline to be Presented at AACR 102nd Annual Meet
[ Mon, Mar 28th 2011 ] - Market Wire
A.P. Pharma Announces Fourth Quarter and Full Yea .. 0 Financial Results and Provides Corporate Update
Sun, March 27, 2011
[ Sun, Mar 27th 2011 ] - Market Wire
Helix BioPharma Announces $3.9 Million Private Placement
[ Sun, Mar 27th 2011 ] - Market Wire
Champions Announces Technology Collaboration Util .. Technology Platform for Oncology Drug Developmen
Fri, March 25, 2011
[ Fri, Mar 25th 2011 ] - Market Wire
Edwards Lifesciences to Be Added to the S&P 500 Index
[ Fri, Mar 25th 2011 ] - Market Wire
Neurologix Announces Year End 2010 Results
[ Fri, Mar 25th 2011 ] - Market Wire
Biotonix Announces Results for the 2010 Fourth Quarter and Fiscal Year
[ Fri, Mar 25th 2011 ] - Market Wire
ISOTECHNIKA REPORTS FULL YEAR AND FOURTH QUARTER 2010 FINANCIAL RESULTS
[ Fri, Mar 25th 2011 ] - Market Wire
PacificHealth Laboratories Board Names New Chairman
[ Fri, Mar 25th 2011 ] - Market Wire
Belo Sun Announces Closing of $51.8 Million Equit .. ring Including Exercise in Full of Over-Allotment
[ Fri, Mar 25th 2011 ] - Market Wire
HealthSpring, Inc. Announces Pricing of Public Offering of Common Stock
[ Fri, Mar 25th 2011 ] - Market Wire
Long-Term Safety Data Demonstrated VIMOVOTM Is Ge .. hritis Patients at Risk for NSAID-Associated Gast
[ Fri, Mar 25th 2011 ] - Market Wire
Celsion Corporation Reports Year End 2010 Financial Results and Provides Business Update
[ Fri, Mar 25th 2011 ] - Market Wire
Teleflex Announces Global Distribution Agreement for POLYSITE® Implantable Infusion Ports
Thu, March 24, 2011
[ Thu, Mar 24th 2011 ] - Market Wire
Gilead fija precio de obligaciones senior no garantizadas por valor de $1.000 millones
[ Thu, Mar 24th 2011 ] - Market Wire
CPEX Stockholders Approve $27.25 Per Share Merger Agreement with FCB I Holdings
[ Thu, Mar 24th 2011 ] - Market Wire
Baxter International Inc. First Quarter 2011 Financial Results Conference Call
[ Thu, Mar 24th 2011 ] - Market Wire
Hi-Tech Pharmacal Receives Final Approval for Lidocaine HCl Jelly, 2%
[ Thu, Mar 24th 2011 ] - Market Wire
Portola Pharmaceuticals to Regain Global Rights for Investigational Medicine Betrixaban from Merck
[ Thu, Mar 24th 2011 ] - Market Wire
Abiomed to Host PROTECT II Investor Meeting at ACC 2011
[ Thu, Mar 24th 2011 ] - Market Wire
Geron to Webcast Analyst and Investor Meeting on Companya?s Oncology Programs on March 29, 2011
[ Thu, Mar 24th 2011 ] - Market Wire
West and CareFusion Announce Plans to Develop an Innovative Needle-Free Vented Vial Access Device
[ Thu, Mar 24th 2011 ] - Market Wire
Healthcare Acquisition Activity on the Rise as Key Patents Run Out
[ Thu, Mar 24th 2011 ] - Market Wire
Oncolytics Biotech® Inc. Completes Patient E .. nical Trial Investigating REOLYSIN® in Combi
[ Thu, Mar 24th 2011 ] - Market Wire
Unigenea?s Oral Peptide Drug Delivery Technology .. ine Phase 3 Results from Tarsaa?s ORACAL Trial of
[ Thu, Mar 24th 2011 ] - Market Wire
Fase III klinische trial van Gileads onderzoeksge .. et aan primaire doelstelling voor eerste 48 weken
Wed, March 23, 2011
[ Wed, Mar 23rd 2011 ] - Market Wire
AdCare Health Systems Reports Record Fourth Quarter and Full Year 2010 Results
[ Wed, Mar 23rd 2011 ] - Market Wire
Affymax and Takeda to Present Additional Peginesa .. Patients at the National Kidney Foundation (NKF)
[ Wed, Mar 23rd 2011 ] - Market Wire
El ensayo clnico de Fase III del frmaco en fase d .. itegravir, supera el objetivo principal de 48 sem
[ Wed, Mar 23rd 2011 ] - Market Wire
A.M. Best Withdraws Ratings of Priority Health Ca .. nc. and Peninsula Health Care, Inc. Due to Merger
[ Wed, Mar 23rd 2011 ] - Market Wire
Mesa Uranium Files 43-101 Report, Expands the Green Energy Project
[ Wed, Mar 23rd 2011 ] - Market Wire
Allezoe (ALZM) Announces Organ Transport Systems' Medical Advisory Members
[ Wed, Mar 23rd 2011 ] - Market Wire
Opexa to Present Tovaxin® Data at 2011 American Academy of Neurology Annual Meeting
[ Wed, Mar 23rd 2011 ] - Market Wire
Prana Biotechnology Limited Raises A$6.12 Million in a Private Placement
[ Wed, Mar 23rd 2011 ] - Market Wire
POZEN Announces Licensing Deal with Cilag GmbH, A .. Johnson & Johnson, for MT 400, Migraine Treatment
[ Wed, Mar 23rd 2011 ] - Market Wire
Nordion announces Phase III clinical trial to eva .. or liver metastases in colorectal cancer patients
[ Wed, Mar 23rd 2011 ] - Market Wire
CPEX Urges Stockholders to Consider the Facts of the Certain All-Cash FCB Transaction
[ Wed, Mar 23rd 2011 ] - Market Wire
Announcement of the Execution of a License Agreement for Unoprostone
Tue, March 22, 2011
[ Tue, Mar 22nd 2011 ] - Market Wire
New Acetadote® Formulation Now Available in the U.S.
[ Tue, Mar 22nd 2011 ] - Market Wire
Amyris aumenta sua capacidade de produo atrav©s de acordo com a Paraso Bioenergia
[ Tue, Mar 22nd 2011 ] - Market Wire
ISTA Pharmaceuticals Highlights BEPREVE(R) Clinic .. Academy of Allergy, Asthma and Immunology (AAAAI)
[ Tue, Mar 22nd 2011 ] - Market Wire
Hi-Tech Pharmacal Receives Final Approval for Ranitidine Syrup
[ Tue, Mar 22nd 2011 ] - Market Wire
LABOPHARM ANNOUNCES WORKFORCE REDUCTION AND APPOINTMENT OF NEW CFO
[ Tue, Mar 22nd 2011 ] - Market Wire
Radient Pharmaceuticals Receives Additional Deficiency Notice From NYSE Amex
[ Tue, Mar 22nd 2011 ] - Market Wire
POZEN Files Motion for Preliminary Injunction in Treximet Patent Litigation
[ Tue, Mar 22nd 2011 ] - Market Wire
Amyris Adds Additional Production Capacity Through Agreement With Paraso Bioenergia
[ Tue, Mar 22nd 2011 ] - Market Wire
Pro-Pharmaceuticals Expands Patent Portfolio with New Patents in the U.S. and Australia
[ Tue, Mar 22nd 2011 ] - Market Wire
Emergent BioSolutions to Present at Needham & Company Healthcare Conference
[ Tue, Mar 22nd 2011 ] - Market Wire
Schiff Nutrition International, Inc. Announces Fiscal 2011 Third Quarter Results
[ Tue, Mar 22nd 2011 ] - Market Wire
Given Imaging to Present at the 10th Annual Needham Healthcare Conference
Mon, March 21, 2011
[ Mon, Mar 21st 2011 ] - Market Wire
2010 FOURTH QUARTER AND YEAR END FINANCIAL RESULTS
[ Mon, Mar 21st 2011 ] - Market Wire
U.S. Physical Therapy to Present at the Sidoti Fi .. nual Emerging Growth Institutional Investor Forum
[ Mon, Mar 21st 2011 ] - Market Wire
30 p.m. ET
[ Mon, Mar 21st 2011 ] - Market Wire
Anacor Pharmaceuticals Secures $30 Million Loan Facility
[ Mon, Mar 21st 2011 ] - Market Wire
RXi Pharmaceuticals Presents New Preclinical RNAi .. one Mechanism and Biology of Silencing Conference
[ Mon, Mar 21st 2011 ] - Market Wire
Hi-Tech Pharmacal Acquires Nystatin Oral Suspension ANDA
[ Mon, Mar 21st 2011 ] - Market Wire
Amyris and U.S. Venture Announce Plans for Joint Venture in Development of Renewable Lubricants
[ Mon, Mar 21st 2011 ] - Market Wire
Biotech Sector Is a Hotbed of Takeover Speculation
[ Mon, Mar 21st 2011 ] - Market Wire
Teleflex Announces Retirement of 2004 Senior Notes
[ Mon, Mar 21st 2011 ] - Market Wire
Given Imaging Wins Patent Infringement Lawsuit in Germany
[ Mon, Mar 21st 2011 ] - Market Wire
XenoPort Reports Results from a Phase 2b Clinical .. il as Adjunctive Treatment for Patients with GERD
[ Mon, Mar 21st 2011 ] - Market Wire
Santarus and Pharming Announce RHUCIN Poster at A .. Allergy, Asthma & Immunology 2011 Annual Meeting
Sun, March 20, 2011
[ Sun, Mar 20th 2011 ] - Market Wire
Curis Announces Positive Results in Genentech Piv .. rial of GDC-0449 in Advanced Basal Cell Carcinoma
Fri, March 18, 2011
[ Fri, Mar 18th 2011 ] - Market Wire
Forest Laboratories Announces Expiration of Hart- .. o Waiting Period for Acquisition of Clinical Data
[ Fri, Mar 18th 2011 ] - Market Wire
The Law Firm of Levi & Korsinsky, LLP Launches an .. Breaches of Fiduciary Duty by the Board of Therag
[ Fri, Mar 18th 2011 ] - Market Wire
Allezoe (ALZM) Announces Organ Transport Systems .. paring for Clinical Trials; Will Prioritize Heart
[ Fri, Mar 18th 2011 ] - Market Wire
Comit© voor geneesmiddelen voor menselijk gebrui .. deelt positief over nieuwe anticonceptie NOMAC-E2
[ Fri, Mar 18th 2011 ] - Market Wire
CPEX Pharmaceuticals Affirms Recommendation That Stockholders Vote for Merger Agreement With FCB
[ Fri, Mar 18th 2011 ] - Market Wire
Rotech Healthcare Inc. Announces Closing of Priva .. Offering of $290 Million Senior Second Lien Notes
[ Fri, Mar 18th 2011 ] - Market Wire
Committee for Medicinal Products for Human Use (C .. Opinion for New Contraception Offering, NOMAC-E2
[ Fri, Mar 18th 2011 ] - Market Wire
Teva Receives Positive Opinion for NOMAC/E2 from the European Committee for Medicinal Products
[ Fri, Mar 18th 2011 ] - Market Wire
Affymax Announces Pricing of Public Offering of Common Stock
[ Fri, Mar 18th 2011 ] - Market Wire
Algoma Central Corporation Announces Increase to Bought Deal Financing
[ Fri, Mar 18th 2011 ] - Market Wire
Cytokinetics Announces Fundamental Research in th .. yosin Activation Published in the Journal Science
[ Fri, Mar 18th 2011 ] - Market Wire
Declarao da Covidien sobre o impacto do terremoto japons
Thu, March 17, 2011
[ Thu, Mar 17th 2011 ] - Market Wire
Covidien Statement on the Impact of the Japanese Earthquake
[ Thu, Mar 17th 2011 ] - Market Wire
HearUSA Responds to Siemens Filing
[ Thu, Mar 17th 2011 ] - Market Wire
SunCoast RHIO Joins Connect HIN - Florida Health Information Network (FLHIN)
[ Thu, Mar 17th 2011 ] - Market Wire
CPEX Pharmaceuticals Advises Stockholders to Take .. Response to Mangrove Partnersa? Revised Proposal
[ Thu, Mar 17th 2011 ] - Market Wire
Antrim Energy Inc. Announces Closing of Financing
[ Thu, Mar 17th 2011 ] - Market Wire
Radient Pharmaceuticals Hires DLA Piper to Defend Company Against Class Action Lawsuit
[ Thu, Mar 17th 2011 ] - Market Wire
Self Funding Administrators Corporation Joins American CareSource's Growing Client Portfolio
[ Thu, Mar 17th 2011 ] - Market Wire
ImmuCell Announces Sales and Marketing Collaboration With AgriLabs
[ Thu, Mar 17th 2011 ] - Market Wire
Prime Equity Research Initiates Independent Coverage On Fresh Start
[ Thu, Mar 17th 2011 ] - Market Wire
Oncolytics Biotech® Inc. Announces 2010 Year End Results
[ Thu, Mar 17th 2011 ] - Market Wire
Alnylam Responds to Tekmira Complaint
[ Thu, Mar 17th 2011 ] - Market Wire
AngioDynamics to Report Fiscal 2011 Third Quarter .. Results and Hold Conference Call on April 5, 2011
Wed, March 16, 2011
[ Wed, Mar 16th 2011 ] - Market Wire
El 1 de julio se retira el CEO de Covidien; ya se ha nombrado el sucesor
[ Wed, Mar 16th 2011 ] - Market Wire
Covidien elige como presidente y director ejecutivo a Jose E. Almeida
[ Wed, Mar 16th 2011 ] - Market Wire
St. Jude Medical Celebrates Two Millionth Mechanical Heart Valve Implant
[ Wed, Mar 16th 2011 ] - Market Wire
PATIENT HOME MONITORING ANNOUNCES NEW CHIEF FINANCIAL AND OPERATIONS OFFICER
[ Wed, Mar 16th 2011 ] - Market Wire
Study Shows SANUWAVEa?s Dermapace is Significantl .. ric Oxygen Therapy in Healing Chronic Diabetic Fo
[ Wed, Mar 16th 2011 ] - Market Wire
Covidien Elects Jose E. Almeida President and Chief Executive Officer
[ Wed, Mar 16th 2011 ] - Market Wire
Covidien CEO to Retire July 1; Successor Named
[ Wed, Mar 16th 2011 ] - Market Wire
Covidiens CEO scheidet am 1. Juli aus dem Amt; Nachfolger ernannt
[ Wed, Mar 16th 2011 ] - Market Wire
CEO di Covidien in pensione dal 1 luglio - nominato successore
[ Wed, Mar 16th 2011 ] - Market Wire
TSO3 DISCLOSES FOURTH QUARTER AND FULL YEAR 2010 .. SCAL RESULTS AND UPDATES ON SUBSEQUENT ACTIVITIES
[ Wed, Mar 16th 2011 ] - Market Wire
Amedisys Presents Home Care and Hospice Face-to-Face Requirements Webinar to Health Care Leaders
[ Wed, Mar 16th 2011 ] - Market Wire
AlphaRx Provides Corporate and Development Update
Tue, March 15, 2011
[ Tue, Mar 15th 2011 ] - Market Wire
Covidien bepaalt contant kwartaaldividend en maak .. n van jaarlijkse algemene vergadering 2011 bekend
[ Tue, Mar 15th 2011 ] - Market Wire
Covidien Declares Quarterly Cash Dividend and Announces Results from 2011 Annual General Meeting
[ Tue, Mar 15th 2011 ] - Market Wire
Exelixis Announces Exercise in Full of Option to .. es and Closing of Public Offering of Common Stock
[ Tue, Mar 15th 2011 ] - Market Wire
Concentra Successfully Deploys ZeOmegaa?s Integrated Workflow Solution
[ Tue, Mar 15th 2011 ] - Market Wire
Seattle Genetics and Millennium Expand Antibody-Drug Conjugate Collaboration
[ Tue, Mar 15th 2011 ] - Market Wire
Biomoda Focuses on Optimizing CyPath® Diagnostic Assay
[ Tue, Mar 15th 2011 ] - Market Wire
Progenics Pharmaceuticals Announces Fourth Quarter and Year-End 2010 Financial Results
[ Tue, Mar 15th 2011 ] - Market Wire
Unigene Doses First Patient in Phase 2 Oral PTH S .. Treatment of Osteoporosis in Postmenopausal Women
[ Tue, Mar 15th 2011 ] - Market Wire
Alnylam Pharmaceuticals Reaches Settlement in Litigation Regarding Tuschl Patents
[ Tue, Mar 15th 2011 ] - Market Wire
Merck to Present at Barclays Capital 2011 Global Healthcare Conference
[ Tue, Mar 15th 2011 ] - Market Wire
Pro-Pharmaceuticals Reports Full Year and Fourth Quarter 2010 Financial Results
[ Tue, Mar 15th 2011 ] - Market Wire
Illumina Prices $800 Million Convertible Senior Notes
Mon, March 14, 2011
[ Mon, Mar 14th 2011 ] - Market Wire
Incytea?s Ruxolitinib (INCB18424) Meets Primary Endpoint in Second Phase III Study
[ Mon, Mar 14th 2011 ] - Market Wire
Human Genome Sciences Invites Investors to Listen .. st of Presentation at Barclays Capital Conference
[ Mon, Mar 14th 2011 ] - Market Wire
Teva to Present at the Barclays Capital 2011 Global Healthcare Conference
[ Mon, Mar 14th 2011 ] - Market Wire
Health Net, Inc. Investigating Unaccounted-for Server Drives
[ Mon, Mar 14th 2011 ] - Market Wire
30 AM E.T.
[ Mon, Mar 14th 2011 ] - Market Wire
Repligen Reports Positive Phase 3 Clinical Trial Results for RG1068 in Pancreatic Imaging
[ Mon, Mar 14th 2011 ] - Market Wire
Bristol-Myers Squibb Awards Grant to the American .. tion to Address U.S. HIV Medical Workforce Shorta
[ Mon, Mar 14th 2011 ] - Market Wire
Positron to Launch Indium Oxine as Initial Product Manufactured at Crown Point Facility
[ Mon, Mar 14th 2011 ] - Market Wire
Invacare President and CEO, Gerald B. Blouch, Presenting at Sidoti & Company, LLC Conference
[ Mon, Mar 14th 2011 ] - Market Wire
Thermo Fisher Scientific Extends Legacy of Innovation at Pittcon 2011
[ Mon, Mar 14th 2011 ] - Market Wire
GTSO Eyes April for First Shipment of Mongolian Rare Earth Ore

Geron to Webcast Analyst and Investor Meeting on Companya?s Oncology Programs on March 29, 2011


//health-fitness.news-articles.net/content/2011/ .. mpanya-s-oncology-programs-on-march-29-2011.html
Published in Health and Fitness on Thursday, March 24th 2011 at 5:41 GMT by Market Wire   Print publication without navigation


MENLO PARK, Calif.--([ BUSINESS WIRE ])--Geron Corporation (NASDAQ:GERN) today announced that it will host a live webcast of the analyst and investor meeting on its oncology programs being held in New York from 12:15 p.m. to 1:30 p.m. EDT on Tuesday, March 29, 2011.

Members of Gerona™s oncology team and management, including Stephen M. Kelsey, M.D., FRCP, FRCPath, Executive Vice President and Chief Medical Officer and Monic Stuart, M.D., Executive Medical Director, will present the progress of the companya™s anti-cancer therapies in Phase 2 clinical development. The presentation will focus on the companya™s telomerase inhibitor drug (imetelstat sodium - GRN163L) and the recently in-licensed peptide-conjugated paclitaxel derivative designed to penetrate the blood-brain barrier (GRN1005).

The webcast for the live audio and slide presentation will be available at [ http://phx.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&c=67323&eventID=3915265 ]. The presentation will be archived for replay and available at the same address one hour after conclusion of the live event for a period of 30 days. It is recommended that listeners log on 15 minutes early in order to register and download any necessary software.

About Geron

Geron is developing first-in-class biopharmaceuticals for the treatment of cancer and chronic degenerative diseases. The company is advancing anti-cancer therapies through multiple Phase 2 clinical trials in different cancers by targeting the enzyme telomerase and with a compound designed to penetrate the blood-brain barrier. The company is developing cell therapy products from differentiated human embryonic stem cells for multiple indications, including central nervous system (CNS) disorders, heart failure, diabetes and osteoarthritis, and has initiated a Phase 1 clinical trial in spinal cord injury. For more information about Geron, visit [ www.geron.com ].


Publication Contributing Sources